Esperion Therapeutics Inc (ESPR) — Cash Flow-to-Debt Ratio
Esperion Therapeutics Inc (ESPR) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of $-4.29 Million could theoretically repay 0% of its total liabilities ($815.38 Million) in one year. See Esperion Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Esperion Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Esperion Therapeutics Inc across 18 annual periods. Also explore net asset momentum of Esperion Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Esperion Therapeutics Inc (1999–2024)
Year-by-year debt coverage analysis for Esperion Therapeutics Inc. For market capitalisation and broader financial context, see Esperion Therapeutics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | $-23.65 Million | $732.54 Million | ▲ +84.3% |
| 2023 | -0.21x | $-135.49 Million | $660.79 Million | ▲ +32.9% |
| 2022 | -0.31x | $-174.83 Million | $571.72 Million | ▲ +32.9% |
| 2021 | -0.46x | $-263.81 Million | $578.53 Million | ▼ -140.6% |
| 2020 | -0.19x | $-85.18 Million | $449.39 Million | ▲ +47.6% |
| 2019 | -0.36x | $-70.34 Million | $194.50 Million | ▲ +84.3% |
| 2018 | -2.31x | $-148.64 Million | $64.33 Million | ▲ +41.7% |
| 2017 | -3.96x | $-131.30 Million | $33.14 Million | ▼ -37.9% |
| 2016 | -2.87x | $-47.73 Million | $16.61 Million | ▲ +37.4% |
| 2015 | -4.59x | $-38.16 Million | $8.31 Million | ▼ -40.3% |
| 2014 | -3.27x | $-32.02 Million | $9.79 Million | ▲ +24.1% |
| 2013 | -4.31x | $-18.11 Million | $4.20 Million | ▼ -885.1% |
| 2012 | -0.44x | $-10.81 Million | $24.70 Million | ▲ +60.3% |
| 2011 | -1.10x | $-9.07 Million | $8.24 Million | ▲ +47.5% |
| 2002 | -2.10x | $-26.56 Million | $12.66 Million | ▼ -9.1% |
| 2001 | -1.92x | $-22.77 Million | $11.84 Million | ▼ -9.1% |
| 2000 | -1.76x | $-17.95 Million | $10.19 Million | ▼ -16.4% |
| 1999 | -1.51x | $-7.85 Million | $5.18 Million | — |